HBIO | tickerfilter.com

Fundamental analysis

10%

Profitability 0%

Dept financing 13%

Liquidity 43%

Performance 12%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-1.90%

1 Month

-32.42%

3 Months

-78.14%

6 Months

-84.39%

1 Year

-89.69%

2 Year

-93.57%

Key data

Stock price

$0.38

P/E Ratio

0.00

DAY RANGE

$0.37 - $0.40

EPS

-$0.28

52 WEEK RANGE

$0.36 - $4.08

52 WEEK CHANGE

-$89.99

MARKET CAP

92.031 M

YIELD

N/A

SHARES OUTSTANDING

43.611 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

05-06-2025

BETA

1.69

PUBLIC FLOAT

AVERAGE 10 VOLUME

$369,395

AVERAGE 30 VOLUME

$362,099

Company detail

CEO: James W. Green
Region: US
Website: harvardbioscience.com
Employees: 490
IPO year: 2001

Issue type: Common Stock
Market: XNAS
Industry: Measuring And Control Equipment/Lab Analytical Instruments
Sector: Manufacturing

Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as well as instruments and accessories for tissue and organ-based lab research.

HBIO - HARVARD BIOSCIENCE INC